Back
Evoke Pharma Vs. Repligen Industry Stock Comparison
Sell
37
EVOK
Evoke Pharma
Last Price:
5.35
Seasonality Move:
-7.28%
Sell
47
RGEN
Repligen
Last Price:
136.78
Seasonality Move:
4.04%
Sell
37
Evoke Pharma (EVOK)
is a Sell
Is Evoke Pharma a Buy, Sell or Hold?
- The current Evoke Pharma [EVOK] share price is $5.25. The Score for EVOK is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- EVOK is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
47
Repligen (RGEN)
is a Sell
Is Repligen a Buy, Sell or Hold?
- The current Repligen [RGEN] share price is $136.71. The Score for RGEN is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- RGEN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EVOK Stock Price Chart
What is Evoke Pharma's stock price today?
-
The Evoke Pharma share price today is $5.25
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EVOK is experiencing slight selling pressure.
EVOK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.11 | Buy |
| Relative Strength Index (14 RSI): | 59.82 | Buy |
| Chaikin Money Flow: | -82214 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.07 - 4.95) | Buy |
| Bollinger Bands (100): | (4.63 - 6.39) | Sell |
RGEN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.4 | Sell |
| Relative Strength Index (14 RSI): | 41.07 | Sell |
| Chaikin Money Flow: | -470643 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (139.77 - 146.85) | Sell |
| Bollinger Bands (100): | (129.08 - 158.92) | Sell |
EVOK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.97 | Buy |
| 20-day SMA: | 4.62 | Buy |
| 50-day SMA: | 4.83 | Buy |
| 200-day SMA: | 6.81 | Sell |
| 8-day EMA: | 4.99 | Buy |
| 20-day EMA: | 4.79 | Buy |
| 50-day EMA: | 4.96 | Buy |
| 200-day EMA: | 7.94 | Sell |
RGEN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 143.28 | Sell |
| 20-day SMA: | 142.66 | Sell |
| 50-day SMA: | 149.55 | Sell |
| 200-day SMA: | 163.47 | Sell |
| 8-day EMA: | 141.88 | Sell |
| 20-day EMA: | 143.37 | Sell |
| 50-day EMA: | 145 | Sell |
| 200-day EMA: | 155.09 | Sell |
Evoke Pharma Earnings Growth & EVOK Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $24.34 per share, and an increase next year of $2.66 per share.
Repligen Earnings Growth & RGEN Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.27 per share, and an increase next year of $0.44 per share.
Evoke Pharma Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Repligen Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||